Long-term effects of hydrolyzed formulae on atopic diseases in the GINI study

TY - JOUR

T1 - Long-term effects of hydrolyzed formulae on atopic diseases in the GINI study

AU - Gappa, Monika

AU - Filipiak-Pittroff, Birgit

AU - Libuda, Lars

AU - von Berg, Andrea

AU - Koletzko, Sibylle

AU - Bauer, Carl Peter

AU - Heinrich, Joachim

AU - Schikowski, Tamara

AU - Berdel, Dietrich

AU - Standl, Marie

N1 - Funding Information: Dr. Gappa reports grants from Nestlé Vevey, Switzerland, during the conduct of the study. Dr. Filipiak‐Pittroff has nothing to disclose. Dr. Libuda is member of the German National Breastfeeding Committee. Dr. von Berg reports grants and personal fees from Nestlé Vevey, Switzerland, and Nestlé Nutrition Institute, Germany, during the conduct of the study. Dr. Koletzko reports grants from Mead Johnson Company during the conduct of the study; personal fees from Nestle, Danone, Biocodex, Shire, AbbVie, R‐Biopharm, Vifor, Pharmacosmos, Celgene, Thermo Fisher, Janssen, Pfizer, Takeda, Berlin‐Chemie, Mead Johnson, grants from BioGaia outside the submitted work. Dr. Bauer has nothing to disclose. Dr. Heinrich has nothing to disclose. Dr. Schikowski has nothing to disclose. Dr. Berdel has nothing to disclose. Dr. Standl has nothing to disclose. Funding Information: The GINI study was mainly supported for the first 3 years of the Federal Ministry for Education, Science, Research and Technology. The 4‐year, 6‐year, 10‐year, 15‐year, and 20‐year follow‐up examinations of the GINI study were covered from the respective budgets of the 5 study centers (Helmholtz Zentrum Munich (former GSF), Research Institute at Marien‐Hospital Wesel, LMU Munich, TU Munich and from 6 years onwards also from IUF—Leibniz Research Institute for Environmental Medicine at the University of Düsseldorf) and a grant from the Federal Ministry for Environment (IUF Düsseldorf, FKZ 20462296). Further, the 15‐year follow‐up examination of the GINI study was supported by the Commission of the European Communities, the 7th Framework Program: MeDALL project. The 15‐year and 20‐year follow‐up examinations were additionally supported by the companies Mead Johnson and Nestlé. Funding Information: The authors thank all the families for their participation in the GINI study. Furthermore, we thank all members of the GINI Study Group for their excellent work and Dr. Carla Harris for language editing. The GINI Study group consists of the following: Institute of Epidemiology, Helmholtz Zentrum M?nchen, German Research Center for Environmental Health, Neuherberg (Standl M, Heinrich J, Schulz H, Ferland M, Flexeder C, Zeller C, Thiering E, Harris C, Markevych I); Department of Pediatrics, Marien-Hospital, Wesel (Berdel D, von Berg A, Gappa M, Filipiak-Pittroff B, Libuda L, Bisdorf K, Frei O); LMU Klinikum of the University of Munich, Dr von Hauner Children?s Hospital (Koletzko S, Werkstetter K); Child and Adolescent Medicine, University Hospital rechts der Isar of the Technical University Munich (Bauer CP, Hoffmann U); IUF-Environmental Health Research Institute, D?sseldorf (Schikowski T, Link E, Kr?mer U, Altug H).

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85097992862&partnerID=8YFLogxK

U2 - 10.1111/all.14709

DO - 10.1111/all.14709

M3 - Letter

C2 - 33320352

AN - SCOPUS:85097992862

SN - 0105-4538

VL - 76

SP - 1903

EP - 1907

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 6

ER -